Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy.

Voltin CA, Gödel P, Beckmann L, Heger JM, Kobe C, Kutsch N, Borchmann P, Dietlein M, Herrmann K, Stelljes M, Rahbar K, Lenz G, Reinhardt HC, Teichert M, Noppeney R, Albring JC, Seifert R, von Tresckow B, Flossdorf S, Hanoun C

Open source

DOI
10.1097/hs9.0000000000000817
Published
2023 Jan
Container
HemaSphere
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/hs9.0000000000000817,
  title = {Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy.},
  author = {Voltin CA and Gödel P and Beckmann L and Heger JM and Kobe C and Kutsch N and Borchmann P and Dietlein M and Herrmann K and Stelljes M and Rahbar K and Lenz G and Reinhardt HC and Teichert M and Noppeney R and Albring JC and Seifert R and von Tresckow B and Flossdorf S and Hanoun C},
  year = {2023},
  journal = {HemaSphere},
  doi = {10.1097/hs9.0000000000000817},
  url = {https://doi.org/10.1097/hs9.0000000000000817}
}

RIS

TY  - JOUR
TI  - Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy.
AU  - Voltin CA
AU  - Gödel P
AU  - Beckmann L
AU  - Heger JM
AU  - Kobe C
AU  - Kutsch N
AU  - Borchmann P
AU  - Dietlein M
AU  - Herrmann K
AU  - Stelljes M
AU  - Rahbar K
AU  - Lenz G
AU  - Reinhardt HC
AU  - Teichert M
AU  - Noppeney R
AU  - Albring JC
AU  - Seifert R
AU  - von Tresckow B
AU  - Flossdorf S
AU  - Hanoun C
PY  - 2023
JO  - HemaSphere
DO  - 10.1097/hs9.0000000000000817
UR  - https://doi.org/10.1097/hs9.0000000000000817
ER  - 

APA

CA, V., P, G., L, B., JM, H., C, K., N, K., P, B., M, D., K, H., M, S., K, R., G, L., HC, R., M, T., R, N., JC, A., R, S., B, V. T., S, F., & C, H. (2023). Outcome Prediction in Patients With Large B-cell Lymphoma Undergoing Chimeric Antigen Receptor T-cell Therapy.. HemaSphere. https://doi.org/10.1097/hs9.0000000000000817

Source records